ARCHIVES

FDA Approves Avastin For Recurrent NSCLC

This article is from The Cancer Letter archive.

Vol. 29 No. 10 | October 27, 2006

Download PDF Visit The Full Archive

Related Articles

ACS to Purchase $1.5 Million In animal Interferon, Offer it for Laboratory Studies

July 13, 1984

Nine Cancer Act Changes Considered By NCAB Subcommittee

September 3, 1976

UNM Gets $1.8 Million For Nanotechnology Center

February 18, 2011

A Patchwork Of Policies Emerges As Insurers Tighten Payments For ESAs.

March 30, 2007

Ending Breast Cancer by 2020? NBCC President Fran Visco Discusses the Goal

January 25, 2013

RF Numbers To Drop Noticeably Soon, Upton Tells AACR

April 14, 1978